Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe

• Autors principals: Walleser S (Autor), Ray J (Autor), Bischoff H (Autor), Vergnenègre A (Autor), Rosery H (Autor), Chouaid C (Autor), Heigener D (Autor), de Castro Carpeño J (Autor), Tiseo M (Autor), Walzer S (Autor)
• Format: Llibre
• Publicat: Dove Medical Press, 2012-09-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Silke Walleser,1 Joshua Ray,2 Helge Bischoff,3 Alain Vergnenègre,4 Hubertus Rosery,5 Christos Chouaid,6 David Heigener,7 Javier de Castro Carpeño,8 Marcello Tiseo,9 Stefan Walzer21Health Economic Consultancy, Renens, Switzerland; 2F Hoffmann-La Roche Pharmaceuticals AG, Basel,...